Skip to main content
SpringerLink
Log in
Book cover

Vorhofflimmern Vorhofflattern pp 3–20Cite as

Epidemiologie, klinischer Verlauf und Prognose

  • Conference paper

  • 32 Accesses

Zusammenfassung

Die Herzrhythmusstörung „Vorhofflimmern“ ist seit langem bekannt: ihre Erstbeschreibung erfolgte vermutlich vor über 300 Jahren durch Harvey, der im Tierexperiment eine undulierende Aktivität der Vorhöfe beobachtete. Die klinische Beobachtung eines schnellen, unregelmäßigen Pulses sowie dessen erfolgreiche Behandlung durch die Gabe von Digitalis geht auf Withering zurück. Die Diagnose „Vorhofflimmern“ ließ sich mit Einführung der Elektrokardiographie erstmals objektivieren; die entsprechenden elektrokardiographischen Befunde sind seit den 20er Jahren bekannt.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Almassi GH, Schowalter T, Nicolosi AC, Aggarwal A, Moritz TE, Henderson WG, Tarazi R, Shroyer AL, Sethi GK, Groyer FL, Hammermeister KE (1997) Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg 226:501–511.

    Article  PubMed  CAS  Google Scholar 

  2. Andresen D, Brüggemann T (1998) Heart rate variability preceding onset of atrial fibrillation. J Cadiovasc Electrophysiol 9:S26–S29.

    CAS  Google Scholar 

  3. Atrial Fibrillation Investigators (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data deriving from five randomized controlled trials. Arch Intern Med 154:1449–1457.

    Article  Google Scholar 

  4. Benjamin EJ, Levy D, Vaziri SM, Dàgostina RB, Belanger AJ, Wolf PA (1994) Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA 271:840–844.

    Article  PubMed  CAS  Google Scholar 

  5. Brand FN, Abbott RD, Kannel WB Wolf PA (1985) Characteristics and prognosis of lone atrial fibrillation. JAMA 254:3449–3453.

    Article  PubMed  CAS  Google Scholar 

  6. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators (1990) The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 323:1505–1511.

    Article  Google Scholar 

  7. Bulbien RS, Knotts-Dolson SM, Plumb VJ (1996) Effect of radiofrequency ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation 94:1585–1591.

    Article  Google Scholar 

  8. Chamberlain Weber R, Petersen ME, Inram A, Briers L, Sutton R (1994) Reasons for reprogramming dual chamber pacemakers to VVI mode: a retrospective review using a computer database. PACE 17:1730–1736.

    Article  Google Scholar 

  9. Connolly SJ, Laupais A, Gent M, Roberts R, Cairns JA, Joyner C (1991) Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 18:349–355.

    Article  PubMed  CAS  Google Scholar 

  10. EAFT (European atrial fibrillation Trial) Study Group (1993) Secondary prevention in non-rheumatic atrial fibrillation after transient attack or minor stroke. Lancet 343:1255–1262.

    Google Scholar 

  11. Eldar M, Canetti M, Rotstein Z, Boyko V, Gottlieb S, Kaplinsky E, Behar S (1998) Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. SPRINT and thrombolytic survey groups. Circulation 97:965–970.

    Article  PubMed  CAS  Google Scholar 

  12. Ettinger PO, Wu CF, dela Cruz C, Weisse AB, Ahmed SS, Regan TJ (1978) Arrhythmias and the „Holiday Heart„: Alcohol-associated cardiac rhythm disorders. Am Heart J 95:555–562.

    Article  PubMed  CAS  Google Scholar 

  13. Ezekowitz MD, Bridgers SL, James KE, Carliner NH, Colling CL, Gornick CC, Krause-Steinrauf H, Kurtzke JF, Nazarian SM, Radford MJ, Rickles FR, 35. Shabetai R, Deykin D (1992) Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med 327:1406–1412.

    Article  PubMed  CAS  Google Scholar 

  14. Ezekowitz MD, James KE, Nazarian SM, Davenport J, Broderick JP, Gupta SR, Thadani V, Meyer ML, Bridgers SL (1995) Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. Circulation 92:2178–2182.

    Article  PubMed  CAS  Google Scholar 

  15. Feinberg WM, Blackhear JL, Laupacis A, Krommal R, Hart RG (1995) Prevalance, age, distribution, and gender of patients with atrial fibrillation. Arch Intern Med 155:469–473.

    Article  PubMed  CAS  Google Scholar 

  16. Fenelon G, Wijns W, Andries E, Brugada P (1996) Tachymyopathy: mechanisms and clinical implication. PACE 19:95–106.

    Article  PubMed  CAS  Google Scholar 

  17. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM (1994) Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 74:236–241.

    Article  PubMed  CAS  Google Scholar 

  18. Furlanello F, Bertoldi A, Dallago M, Galassi A, Fernando F, Biffi A, Mazzone P, pappone C, Chierchia S (1998) Atrial fibrillation in elite athletes. J Cardiovasc Electrophysiol 9:S63–S68.

    PubMed  CAS  Google Scholar 

  19. Gianfranchi L, Brignole M, Menozzi C, Lolli G, Bottom N (1998) Progression of permanent atrial fibrillation after atrioventricular junction ablation and dual-chamber pacemaker implantation in patients with paroxysmal atrial tachyarrhythmias. Am J Cardiol 81:351–354.

    Article  PubMed  CAS  Google Scholar 

  20. Ibrahim B, Sanderson JE, Wright B, Palmer R (1995) Dual chamber pacing: how many patients remain in DDD mode over long term? Br Heart J 74:76–79.

    Article  PubMed  CAS  Google Scholar 

  21. Kannel WB, Abbott RD, Savage DD, Mcnamara PM (1982) Epidemiologic features of chronic atrial fibrillation: the Framingham Study. N Engl J Med 306:1018–1022.

    Article  PubMed  CAS  Google Scholar 

  22. Kannel WB, Abbott RD, Savage DD, McNamara PM (1983) Coronary heart disease and atrial fibrillation: The Framingham Study. Am Heart J 106:389–396.

    Article  PubMed  CAS  Google Scholar 

  23. Kopecky SL, Gersh BJ, McGoon MD, Whisnat JP, Homes DR, Ilstrup DM, Frye RL (1987) The natural history of lone atrial fibrillation. N Engl J Med 317:669–674.

    Article  PubMed  CAS  Google Scholar 

  24. Lake RR, Cullen KJ, Deklerk NH, McCall MG, Rosman DL (1989) Atrial fibrillation in an elderly population. Aust N Z J Med 19:321–326.

    Article  PubMed  CAS  Google Scholar 

  25. Lamas GA, Orav EJ, Stambler BS, Ellenbogen KA, Sgarbossa EB, Huang SK, Marinchak RA, Estes NA 3rd, Mitchell GF, Lieberman EH, Mangione CM, Goldman L (1998) Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. N Engl J Med 338:1097–1104.

    Article  PubMed  CAS  Google Scholar 

  26. Levy S (1998) Epidemiology and classification of atrial fibrillation. J Cardiovasc Electrophysiol 9:S78–S82.

    PubMed  CAS  Google Scholar 

  27. Mattioli AV, Vivoli D, Mattioli G (1998) Influence of pacing modalities on the incidence of atrial fibrillation in patients without prior atrial fibrillation. Eur Heart J 19:282–286.

    Article  PubMed  CAS  Google Scholar 

  28. Murgatroyd F (1997) Modes of onset of spontaneous episodes of atrial fibrillation: implication for the prevention of atrial fibrillation by pacing. In JC Daubert, EN Prystowsky, A Ripart (Hrsg) Prevention of tachyarrhythmias with cardiac pacing. Futura Publishing Company Armonk S53-S65.

    Google Scholar 

  29. Page RL, Wilkinson WE, Clair WK (1994) Asymptomatic arrhythmias in patients with symptomatic atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 89:224–227.

    Article  PubMed  CAS  Google Scholar 

  30. Peters KG, Kienzle MG (1988) Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: complete recovery after restoration of sinus rhythm. Am J Cardiol 85:242–244.

    CAS  Google Scholar 

  31. Petersen P, Godtfredsen, Boysen G, Andersen ED, Andersen B (1989) Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. Lancet 1:75–79.

    Google Scholar 

  32. Reimold SC, Lamas GA, Cantillon CO, Antman EM (1995) Risk factors for the development of recurrent atrial fibrillation: role of pacing and clinical variables. Am Heart J 129:1127–1132.

    Article  PubMed  CAS  Google Scholar 

  33. Sgarbossa EB, Pinski SL, Maloney JD, Simmons TW, Wilkoff BL, Caslte LW, Trohmann RG (1993) Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome. Circulation 88:1045–1053.

    Article  PubMed  CAS  Google Scholar 

  34. Stevenson WG, Stevenson LW, Middelkauff HR, Fonarow GC, Hamilton MA, Woo MA, Saxon LA, Natterson PD, Steimle A, Waiden JA, Tillisch JH (1996) Improving survival for patients with atrial fibrillation and advanced heart failure. JACC 28:1458–1463.

    PubMed  CAS  Google Scholar 

  35. Stroke Prevention in Atrial Fibrillation Investigators (1991) Stroke Prevention in atrial fibrillation study. Circulation 84:527–531.

    Article  Google Scholar 

  36. Tröster S, Schuster HP, Bodmann KF (1991) Vorhofflimmern bei Patienten einer Medizinischen Klinik — ein Marker für Multimorbidität und ungünstige Prognose. Med Klinik 86:338–343.

    Google Scholar 

  37. Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22:983–988.

    Article  PubMed  CAS  Google Scholar 

  38. Wolf PA, Mitchell JB, Baker CS, Kannel WB, D’Agostino RB (1998) Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 158:229–234.

    Article  PubMed  CAS  Google Scholar 

  39. Yamashita T, Murakawa Y, Sezaki K, Inoue M, Hayami N, Shuzui Y, Omata M (1997) Circadian variation of paroxysmal atrial fibrillation. Circulation 96:1537–1541.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. A. Schuchert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Meinertz
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abt. für Kardiologie, Kerckhoff-Klinik, Benekestraße 2-8, 61231, Bad Nauheim, Deutschland

    Jörg Neuzner  & Heinz F. Pitschner  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schuchert, A., Meinertz, T. (2000). Epidemiologie, klinischer Verlauf und Prognose. In: Neuzner, J., Pitschner, H.F. (eds) Vorhofflimmern Vorhofflattern. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-662-13383-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-13383-5_2

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-662-13384-2

  • Online ISBN: 978-3-662-13383-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation